Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rocket Pharmaceuticals
Biotech
Rocket adjusts trajectory, laying off staff and narrowing focus
Rocket is laying off 30% of its staff and focusing on cardiovascular disease, delaying a gene therapy that was on track to win approval next year.
Nick Paul Taylor
Jul 24, 2025 8:05am
Rocket crashes as gene therapy patient dies, FDA imposes hold
May 27, 2025 9:49am
Rocket's gene therapy sets new efficacy bar in ph. 1 heart study
May 16, 2025 10:36am
Rocket gene therapy's flight to approval delayed by FDA
Jun 28, 2024 9:58am
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Mar 29, 2024 9:30am
Rocket boosted by FDA alignment on pivotal gene therapy trial
Sep 13, 2023 9:21am